Copyright
©The Author(s) 2017.
World J Gastroenterol. Jun 28, 2017; 23(24): 4369-4380
Published online Jun 28, 2017. doi: 10.3748/wjg.v23.i24.4369
Published online Jun 28, 2017. doi: 10.3748/wjg.v23.i24.4369
Group | IFN-γ | TNF-α | IL1-β | IL-6 | IL-10 |
Non-colitic | 78.2 ± 7.9c | 121.2 ± 7.0a | 1395.0 ± 136.9a | 421.1 ± 45.3a | 467.1 ± 31.1a |
TNBS control | 125 ± 20.4 | 240.3 ± 34.3 | 2205.0 ± 147.4 | 893.8 ± 105.5 | 675.5 ± 38.6 |
PACO2, 25 mg/kg | 92.1 ± 8.6 | 246.6 ± 34.3 | 1867.0 ± 221.4 | 891.9 ± 87.09 | 674.5 ± 40.4 |
PACO2, 50 mg/kg | 67 ± 11.7c | 167.9 ± 23.6 | 2106.0 ± 128.9 | 563.4 ± 55.5c | 626.9 ± 66.5 |
PACO2, 100 mg/kg | 76.4 ± 12.7c | 205.5 ± 34.5 | 2323.0 ± 154.1 | 649.5 ± 86.9 | 537.4 ± 41.1 |
- Citation: Almeida Junior LD, Quaglio AEV, de Almeida Costa CAR, Di Stasi LC. Intestinal anti-inflammatory activity of Ground Cherry (Physalis angulata L.) standardized CO2 phytopharmaceutical preparation. World J Gastroenterol 2017; 23(24): 4369-4380
- URL: https://www.wjgnet.com/1007-9327/full/v23/i24/4369.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i24.4369